AnnaMarie Meagher

AnnaMarie A. Meagher serves as a Contracting Officer responsible for managing the acquisition of critical industrial and pharmaceutical components for federal operations. She oversees the full lifecycle of procurement activities, from market research and solicitation development to contract award and administration, ensuring compliance with federal acquisition regulations and mission-critical delivery timelines. Her portfolio primarily involves direct purchase contracts for manufactured hardware and specialty chemical products, requiring precise technical specifications and stringent quality control standards. Meagher’s work supports operational readiness across defense and public health sectors, with a focus on reliable, domestically sourced supplies. Her contractor relationships are centered on manufacturers with proven capabilities in precision metal fastening and medicinal formulation. She regularly engages with small- to mid-sized industrial suppliers capable of meeting federal quality assurance requirements, including ISO 9001 and cGMP certifications. While no single vendor dominates her award history, her procurement patterns reflect a preference for established manufacturers with demonstrated capacity for consistent, high-volume production and supply chain resilience. Meagher’s contracting approach is entirely non-set-aside, with 100% of her acquisitions conducted under full and open competition. This reflects a strategic emphasis on technical merit, production capacity, and cost-effectiveness rather than socioeconomic preferences. Her approach prioritizes performance-based outcomes and vendor reliability over programmatic set-asides, aligning with mission needs that demand rapid scalability and stringent regulatory compliance. Her primary procurement focus lies in NAICS 332722 (Bolt, Nut, Screw, Rivet, and Washer Manufacturing), where she acquires high-integrity fasteners for mechanical and aerospace applications, and NAICS 325411 (Medicinal and Botanical Manufacturing), where she procures active pharmaceutical ingredients and compounded botanical extracts. Her technical expertise spans materials science, manufacturing tolerances, and pharmaceutical cGMP standards, positioning her as a specialist in industrial and health-related supply chain acquisitions.